Effect of combined systolic and diastolic functional parameter assessment for differentiation of cardiac amyloidosis from other causes of concentric left ventricular hypertrophy

Circulation: Cardiovascular Imaging

Volumn 6, Issue 6, 2013, Pages 1066-1072

  Liu, Dan ^a   Hu, Kai ^a   Niemann, Markus ^a   Herrmann, Sebastian ^a   Cikes, Maja ^c   Störk, Stefan ^a   Gaudron, Philipp Daniel ^a   Knop, Stefan ^b   Ertl, Georg ^a   Bijnens, Bart ^d,e   Weidemann, Frank ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c KBC Zagreb   (Croatia)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Amyloidosis; Differential diagnosis; Echocardiography; Hypertrophy; Left ventricular

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DECELERATION; ECHOCARDIOGRAPHY; FABRY DISEASE; FEMALE; FRIEDREICH ATAXIA; HEART AMYLOIDOSIS; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; SEGMENTAL LONGITUDINAL PEAK SYSTOLIC STRAIN; SHORTENED DIASTOLIC DECELERATION TIME OF EARLY FILLING;

AMYLOIDOSIS; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR;

AGED; AMYLOIDOSIS; CARDIOMYOPATHIES; DIAGNOSIS, DIFFERENTIAL; DIASTOLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; ROC CURVE; SYSTOLE; VENTRICULAR FUNCTION, LEFT;

EID: 84892165172     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.113.000683     Document Type: Article

References (35)

1. Falk RH. Diagnosis and management of the cardiac amyloidoses. Circulation. 2005; 112:2047-2060.
2. Hamer JP, Janssen S, van Rijswijk MH, Lie KI Amyloid cardiomyopathy in systemic non-hereditary amyloidosis: clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis. Eur Heart J. 1992; 13:623-627.
3. Rahman JE, Helou EF, Gelzer-Bell R, Thompson R.E., Kuo C., Rodriguez ER, Hare JM, Baughman KL, Kasper EK Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004; 43:410-415.
4. Kristen AV, Perz JB, Schonland S.O., Hegenbart U., Schnabel PA, Kristen JH, Goldschmidt H, Katus H.A., Dengler TJ Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail. 2007; 9:617-624.
5. Kyle RA, Gertz MA Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995; 32:45-59.
6. Dubrey SW, Cha K, Anderson J., Chamarthi B, Reisinger J, Skinner M., Falk RH The clinical features of immunoglobulin light-chain (AL) amy-loidosis with heart involvement. QJM. 1998; 91:141-157.
7. Chew C, Ziady GM, Raphael M.J., Oakley CM The functional defect in amyloid heart disease: the "stiff heart," syndrome. Am J Cardiol. 1975; 36:438-444.
8. Belkin RN, Kupersmith AC, Khalique O, Aronow W.S., Chilappa K., Palaniswamy C, Rosenblum WD, Gass A, Ahmed T., Katta US A novel two-dimensional echocardiographic finding in cardiac amyloidosis. Echocardiography. 2010; 27:1171-1176.
9. Baccouche H, Maunz M, Beck T., Gaa E, Banzhaf M, Knayer U., Fogarassy P, Beyer M. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocar-diography. Echocardiography. 2012; 29:668-677.
10. Phelan D, Collier P, Thavendiranathan P., Popović ZB, Hanna M, Plana JC, Marwick TH, Thomas JD. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012; 98:1442-1448.
11. Liu D, Hu K, Niemann M., Herrmann S, Cikes M, Störk S, Beer M., Gaudron PD, Morbach C, Knop S, Geissinger E., Ertl G, Bijnens B, Weidemann F. Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PLoS One. 2013; 8:e56923.
12. Chobanian AV, Bakris GL, Black H.R., Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289:2560-2572.
13. Nagueh SF, Appleton CP, Gillebert T.C., Marino PN, Oh JK, Smiseth OA, Waggoner A.D., Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009; 22:107-133.
14. Kadish AH, Buxton AE, Kennedy H.L., Knight BP, Mason JW, Schuger CD, Tracy C.M., Winters WL Jr, Boone AW, Elnicki M, Hirshfeld JW Jr, Lorell BH, Rodgers GP, Tracy CM, Weitz HH; American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force; International Society for Holter and Noninvasive Electrocardiology. ACC/AHA clinical competence statement on electrocardiography and ambulatory electrocardiography: a report of the ACC/AHA/ACP-ASIM Task Force on Clinical Competence (ACC/AHA Committee to Develop a Clinical Competence Statement on Electrocardiography and Ambulatory Electrocardiography) endorsed by the International Society for Holter and Noninvasive Electrocardiology. Circulation. 2001; 104:3169-3178.
15. Sokolow M, Lyon TP The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J. 1949; 37:161-186.
16. DiCiccio TJ, Efron B. Bootstrap confidence intervals. Stat Sci. 1996; 11:189-228.
17. Cueto-Garcia L., Reeder GS, Kyle R.A., Wood DL, Seward JB, Naessens J, Offord K.P., Greipp PR, Edwards WD, Tajik AJ Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol. 1985; 6:737-743.
18. Falk RH, Plehn JF, Deering T, Schick EC Jr, Boinay P, Rubinow A, Skinner M., Cohen AS Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol. 1987; 59:418-422.
19. St John Sutton MG, Reichek N, Kastor J.A., Giuliani ER Computerized M-mode echocardiographic analysis of left ventricular dysfunction in cardiac amyloid. Circulation. 1982; 66:790-799.
20. Palka P, Lange A, Donnelly J.E., Scalia G., Burstow DJ, Nihoyannopoulos P. Doppler tissue echocardiographic features of cardiac amyloidosis. J Am Soc Echocardiogr. 2002; 15:1353-1360.
21. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography: from technical considerations to clinical applications. J Am Soc Echocardiogr. 2007; 20:234-243.
22. Grossman W, Jones D, McLaurin LP Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975; 56:56-64.
23. Jiang L, Huang Y, Hunyor S., dos Remedios CG. Cardiomyocyte apoptosis is associated with increased wall stress in chronic failing left ventricle. Eur Heart J. 2003; 24:742-751.
24. Brenner DA, Jain M, Pimentel D.R., Wang B., Connors LH, Skinner M, Apstein CS, Liao R. Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res. 2004; 94:1008-1010.
25. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene expression? J Theor Biol. 1982; 99:31-68.
26. Zimmerman SD, Karlon WJ, Holmes J.W., Omens JH, Covell JW Structural and mechanical factors influencing infarct scar collagen organization. Am J Physiol Heart Circ Physiol. 2000; 278:H194-H200.
27. Baltabaeva A, Marciniak M, Bijnens B., Moggridge J, He FJ, Antonios T.F., MacGregor GA, Sutherland GR Regional left ventricular deformation and geometry analysis provides insights in myocardial remodelling in mild to moderate hypertension. Eur J Echocardiogr. 2008; 9:501-508.
28. Lorell BH, Grossman W. Cardiac hypertrophy: the consequences for diastole. J Am Coll Cardiol. 1987; 9:1189-1193.
29. Brutsaert DL, Rademakers FE, Sys S.U., Gillebert TC, Housmans PR Analysis of relaxation in the evaluation of ventricular function of the heart. Prog Cardiovasc Dis. 1985; 28:143-163.
30. Little WC, Ohno M, Kitzman D.W., Thomas JD, Cheng CP Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation. 1995; 92:1933-1939.
31. Garcia MJ, Firstenberg MS, Greenberg N.L., Smedira N., Rodriguez L, Prior D, Thomas JD Estimation of left ventricular operating stiffness from Doppler early filling deceleration time in humans. Am J Physiol Heart Circ Physiol. 2001; 280:H554-H561.
32. Syed IS, Glockner JF, Feng D, Araoz P.A., Martinez MW, Edwards WD, Gertz MA, Dispenzieri A, Oh J.K., Bellavia D., Tajik AJ, Grogan M. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloido-sis. JACC Cardiovasc Imaging. 2010; 3:155-164.
33. Maceira AM, Mohiaddin RH Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson. 2012; 14:28.
34. Feng D, Syed IS, Martinez M, Oh J.K., Jaffe AS, Grogan M, Edwards WD, Gertz M.A., Klarich KW Intracardiac thrombosis and anticoagulation therapy in cardiac amyloidosis. Circulation. 2009; 119:2490-2497.
35. Feng D, Edwards WD, Oh J.K., Chandrasekaran K., Grogan M, Martinez MW, Syed I.S., Syed II, Hughes DA, Lust JA, Jaffe A.S., Gertz MA, Klarich KW Intracardiac thrombosis and embolism in patients with cardiac amy-loidosis. Circulation. 2007; 116:2420-2426.